retatrutide nejm 2023 obesity trial ly3437943 Retatrutide Beat Semaglutide by 7.9% in Phase 2 — Here's the Trial Data Medscape | The investigational triple

For many individuals this may be challenging, so supplementing with whole-foods sources of fiber, including apple pectin, oat fiber, beet fiber, carrot fiber and psyllium husk can help address gaps in dietary fiber intake

These results were consistent both in patients with LVEF of 60% or more and in those 50% or 50%) ( The DAPA-HF, EMPEROR-REDUCED, EMPEROR-Preserved, DELIVER and other trials mentioned above consistently demonstrate the efficacy of SGLT-2i in patients with HF, regardless of LVEF or the presence of diabetes

If you miss a dose, the appropriate action depends on your specific medication and how much time has passed

It's a small detail, but its a profoundly important one